SCN SIGNS INTERNATIONAL LICENSING AGREEMENT WITH AMWAY

(NGM:SCN)

Amway and SCN USA, LLC, a subsidiary of Scandinavian Clinical Nutrition AB (SCN), publicly traded in Sweden and Norway (Ticker: SCN), have established a licensing agreement. This partnership will involve an international license of CUUR, the top selling weight loss product in Sweden, for multilevel marketing (network marketing). CUUR is one of several clinically tested products by SCN USA, LLC.

“Nutrilite is excited to include CUUR in its product line as it is a clinically-tested and patent-pending formula demonstrating statistically significant weight loss, and more importantly, significant fat loss, in a well-controlled human study”, says Robin Dykhouse, Vice-President, Health & Beauty Research & Product Development for Access Business Group, a division of Amway, and manufacturer of Nutrilite™ products.

“This partnership is certainly going to benefit consumers since CUUR will be available in yet another channel of distribution. Amway is one of the most established and recognized nutrition companies and we’re very excited to be working with them in the international licensing of CUUR and future products,” adds Gwen Kent, President of SCN USA, LLC.

This agreement also provides Amway a right of first refusal for products and technologies licensed to SCN developed by the Karolinska Institute, the internationally recognized Swedish institution that awards the Nobel Prize in Medicine. SCN has formed a 10-year, $10 million research agreement with the Karolinska Institute through their Network of Excellence, which will serve to benefit Amway, which also maintains a strong focus on the research and development of new products.

“We are happy SCN USA, LLC has secured this royalty agreement with a prominent dietary supplement brand such as Nutrilite™,” says Ulf Söderberg, CEO of SCN. Nutrilite™ is the world’s leading brand of vitamin, mineral, and dietary supplements.

Amway is a global leader in direct selling, with over three million Independent Business Owners (IBOs) in over 80 countries and territories around the world. No other direct selling company can compare with their longevity, stability, and global reach. For more than 45 years, Amway Corporation has enabled people to have a business of their own. Their business opportunity is now supported by an excellent portfolio of hundreds of high-quality products and brands that can only be purchased through their IBOs.

For further information, please contact:

Ulf Söderberg, CEO, us@scnutrition.com, +46 708 13 22 81

Anders Struksnes, Senior Vice President, as@scnutrition.com, +47 911 98 942

Gwen Kent, President SCN USA, LLC, gk@scnutrition.com, +1 847 226 3273

Scandinavian Clinical Nutrition AB (publ) works in R&D and sales of scientifically documented products within the field of nutrition (nutraceuticals). Established in 2006, SCN maintains a product portfolio with established trademarks, such as CUUR, Membraseven, Coldizin, Immulina and Ledactin. Core competence and strategic alliances, within both R&D and sales, in combination with innovative and scientifically documented products, create the right conditions for profitable growth both in Sweden and in the company’s export markets. The shares of SCN are traded under the ticker “SCN” on Oslo Axess (www.osloaxess.no) and NGM Equity (www.ngm.se).